ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m6A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity

Wang, Qibo; Xie, Haichuan; Peng, Hao; Yan, Jianjian; Han, Limin*; Ye, Gang*南方医科大学
Journal of Oncology2021-12-30DOI: 10.1155/2021/1328444
17被引13阅读
引用收藏
分享

摘要

Objective. N-6-Methyladenosine (m(6)A) is the most prevalent RNA epigenetic modulation in eukaryotic cells, which serves a critical role in diverse physiological processes. Emerging evidences indicate the prognostic significance of m(6)A regulator ZC3H13 in hepatocellular carcinoma (HCC). Herein, this study was conducted for revealing biological functions and mechanisms of ZC3H13 in HCC. Methods. Expression of ZC3H13 was examined in collected HCC and normal tissues, and its prognostic significance was investigated in a public database. Gain/loss of functional assays were presented for defining the roles of ZC3H13 in HCC progression. The specific interactions of ZC3H13 with PKM2 were validated in HCC cells via mRNA stability, RNA immunoprecipitation, and luciferase reporter and MeRIP-qPCR assays. Moreover, rescue experiments were carried out for uncovering the mechanisms. Results. ZC3H13 expression was downregulated in HCC, and its loss was in relation to dismal survival outcomes. Functionally, overexpressed ZC3H13 suppressed proliferation, migration, and invasion and elevated apoptotic levels of HCC cells. Moreover, ZC3H13 overexpression sensitized to cisplatin and weakened metabolism reprogramming of HCC cells. Mechanically, ZC3H13-induced m(6)A modified patterns substantially abolished PKM2 mRNA stability. ZC3H13 facilitated malignant behaviors of HCC cells through PKM2-dependent glycolytic signaling. Conclusion. Collectively, ZC3H13 suppressed the progression of HCC through m(6)A-PKM2-mediated glycolysis and sensitized HCC cells to cisplatin, which offered a fresh insight into HCC therapy.

学科与关键词

关键词
CANCER
相关
加载中…
  • Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner
    Zhang, Chun-Peng*; Huang, Xin-YingHuman Cell, 2023, 36(5): 1741-1754.被引 1
  • Analysis and Validation of circRNA-miRNA Network in Regulating m6A RNA Methylation Modulators Reveals CircMAP2K4/miR-139-5p/YTHDF1 Axis Involving the Proliferation of Hepatocellular Carcinoma
    Chi, Fanwu; Cao, Yong*; Chen, Yuhan*Frontiers in Oncology, 2021, 11: 560506.被引 37
  • Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma
    Deng, Min; Fang, Lin; Li, Shao-Hua; Zhao, Rong-Ce; Mei, Jie; Zou, Jing-Wen; Wei, Wei; Guo, Rong-Ping*Mutagenesis, 2021, 36(5): 369-379.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Oncology
发表日期
2021-12-30
卷期
第 2021 卷
页码
1328444
DOI
10.1155/2021/1328444
期刊收录
NSL
期刊等级
4区
成果收录
SCIE

作者

  • W

    Wang, Qibo (第一作者)

    southern med univ

  • X

    Xie, Haichuan

查看全部 6 位作者收起作者
  • P

    Peng, Hao

    southern med univ

  • Y

    Yan, Jianjian

    southern med univ

  • H

    Han, Limin (通讯)

  • Y

    Ye, Gang (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417